Perioperative Avelumab and Chemotherapy for Gastroesophageal Adenocarcinoma: Long-Term Survival Outcomes.

Alcindor T, Tankel J, Fiset PO, Dehghani M, Bertos N, Mueller C, Cools-Lartigue J, Camilleri-Broet S, Ferri L

Open source

DOI
10.1002/ijc.70749
Published
2026 Sep 17
Container
International journal of cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ijc.70749,
  title = {Perioperative Avelumab and Chemotherapy for Gastroesophageal Adenocarcinoma: Long-Term Survival Outcomes.},
  author = {Alcindor T and Tankel J and Fiset PO and Dehghani M and Bertos N and Mueller C and Cools-Lartigue J and Camilleri-Broet S and Ferri L},
  year = {2026},
  journal = {International journal of cancer},
  doi = {10.1002/ijc.70749},
  url = {https://doi.org/10.1002/ijc.70749}
}

RIS

TY  - JOUR
TI  - Perioperative Avelumab and Chemotherapy for Gastroesophageal Adenocarcinoma: Long-Term Survival Outcomes.
AU  - Alcindor T
AU  - Tankel J
AU  - Fiset PO
AU  - Dehghani M
AU  - Bertos N
AU  - Mueller C
AU  - Cools-Lartigue J
AU  - Camilleri-Broet S
AU  - Ferri L
PY  - 2026
JO  - International journal of cancer
DO  - 10.1002/ijc.70749
UR  - https://doi.org/10.1002/ijc.70749
ER  - 

APA

T, A., J, T., PO, F., M, D., N, B., C, M., J, C., S, C., & L, F. (2026). Perioperative Avelumab and Chemotherapy for Gastroesophageal Adenocarcinoma: Long-Term Survival Outcomes.. International journal of cancer. https://doi.org/10.1002/ijc.70749

Source records